Sort
39,280 grants matching “leukemia”
Mitochondrial determination of response to targeted AML therapies
$381,844Anthony G Letai · Brigham And Women'S Hospital · P01 · FY2014 · CA
Autoimmune encephalomyelitis and Bcl-2- interacting mediator
$381,825Youhai H Chen · University Of Pennsylvania · R01 · FY2007 · AI
T-Cell Targeting for GVHD
$381,812Bruce R. Blazar · University Of Minnesota · R01 · FY2016 · HL
T-Cell Targeting for GVHD
$381,812Bruce R. Blazar · University Of Minnesota · R01 · FY2017 · HL
T-Cell Targeting for GVHD
$381,812Bruce R. Blazar · University Of Minnesota · R01 · FY2018 · HL
CAML in T cell Development and Function
$381,805Richard J Bram · Mayo Clinic Rochester · R01 · FY2011 · AI
Good Manufacturing Practice (GMP) and Immune Assessment Core
$381,786Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
RETROVIRAL VECTOR-MEDIATED LIVER GENE THERAPY FOR MPS I
$381,760Katherine P. Ponder · Washington University · R01 · FY2009 · DK
The roles of pleckstrin-2 as a functional node in erythropoiesis
$381,754Peng Ji · Northwestern University At Chicago · R01 · FY2015 · DK
HuR regulates Th17 cells for promoting autoimmune neuroinflammation
$381,727Shiguang Yu · Thomas Jefferson University · R01 · FY2016 · AI
Molecular characterization of Acute Myeloid Leukemia
$381,721Irving Lerner Weissman · Stanford University · R01 · FY2009 · CA
Projecdt 3 - Modulation of bone environment to enhance response of bone cancers
$381,718John F Dipersio · Washington University · U54 · FY2016 · CA
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
$381,692Peter A Cohen · Mayo Clinic Rochester · P50 · FY2015 · CA
The Role of Dot1L in developing and postnatal heart
$381,687Sylvia M Evans · University Of California, San Diego · R01 · FY2015 · HL
Monokine Gene Expression/Regulation in Lung Injury
$381,687Steven Lynn Kunkel · University Of Michigan At Ann Arbor · R01 · FY2015 · HL
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia
$381,673Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2017 · CA
Architectural Basis of Leptin Transmembrane Signaling
$381,660Georgios Skiniotis · University Of Michigan At Ann Arbor · R01 · FY2011 · DK
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
$381,617Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
$381,617Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Validation of Therapeutic Target Genes in Human Liver Cancer
$381,594Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$381,557Tufts Medical Center · U10 · FY2002 · CA
The histone demethylase JMJD1C in human Acute Myeloid Leukemia
$381,528Nan Zhu · Versiti Wisconsin, Inc. · R37 · FY2021 · CA
Glucocorticoids in Lymphoblastic Leukemia
$381,515Mary V. Relling · St. Jude Children'S Research Hospital · R01 · FY2011 · CA
Intranasal LIF to improve neurological recovery from perinatal hypoxia-ischema
$381,508Steven W Levison · Rbhs-New Jersey Medical School · R01 · FY2020 · NS
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
$381,482Vu Nguyen Ngo · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA